Final results from a prospective, multicenter, non-interventional study (BESREMi-PASS) on the safety of ropeginterferon alfa-2b in 229 patients with polycythemia veraVeronika Buxhofer‐Ausch, Steffen Koschmieder, Kurt Krejcy et al.|Blood|2025Cited by 0